Recent Advances and Future Directions in Lung Cancer — With Dr Ibiayi Dagogo-Jack and Stephen Liu (Proceedings from a Symposium in Partnership with NCOA and SCOS)
Lung Cancer Update
00:00
Lung Cancer - Monotherapy vs Chemotherapy?
Pembrolysmab is what we use. Subimiplimab, a Tezo, are very comparable. If there was any type of formulary restriction, I wouldn't hesitate to make a switch. The Poseidon data in the context of an SDK11 and KRS commutation is very interesting but it's pretty small numbers. And so right now, I'm still chemo I.O. but we're watching sort of long-term outcomes and we're willing to adapt. What do you think about these two antibody conjugates? You know when you say out loud, these ADCs have ridiculous names; they're pronounced entirely differently by everybody.
Transcript
Play full episode
